AEOLUS(SH:600469)2021-04-29 16:00Financial Performance - Operating revenue rose by 45.04% to CNY 1,545,840,926.19 year-on-year[5] - Net profit attributable to shareholders increased by 33.84% to CNY 27,278,524.25 compared to the same period last year[5] - Net profit attributable to shareholders after deducting non-recurring gains and losses surged by 362.06% to CNY 24,676,397.74[5] - The company's operating revenue for Q1 2021 was CNY 1,618,991,104.00, an increase of 48.6% compared to CNY 1,088,296,330.86 in Q1 2020[28] - The net profit for Q1 2021 reached CNY 27,278,524.25, representing a 33.9% increase from CNY 20,381,975.81 in Q1 2020[26] - The total comprehensive income for Q1 2021 was CNY 23,482,798.59, compared to CNY 19,752,594.71 in Q1 2020, reflecting a growth of 18.0%[26] Assets and Liabilities - Total assets increased by 3.64% to CNY 7,775,669,666.74 compared to the end of the previous year[5] - The company’s total liabilities increased to ¥4,860,927,272.04 from ¥4,611,054,200.81, reflecting a rise in both current and non-current liabilities[17] - Total assets as of March 31, 2021, were ¥8,043,526,892.88, compared to ¥7,709,172,323.69 at the end of 2020, marking an increase of approximately 4.3%[22] - Total liabilities increased to ¥4,778,015,327.67 from ¥4,453,999,361.78, indicating a rise of about 7.3%[22] - The company's equity attributable to shareholders rose to ¥3,265,511,565.21 from ¥3,255,172,961.91, reflecting a slight increase of about 0.3%[22] Cash Flow - The company reported a net cash flow from operating activities of CNY 78,339,980.93, up 3.07% year-on-year[5] - The cash flow from operating activities was CNY 1,351,704,343.93 in Q1 2021, an increase from CNY 967,259,985.46 in Q1 2020[31] - The net cash flow from financing activities was -¥11,552,762.76, compared to -¥80,539,701.61 in Q1 2020, showing an improvement[33] - Total cash inflow from operating activities was ¥1,399,033,293.13, up from ¥997,777,348.34 in the previous year, indicating a growth of approximately 40.3%[32] Shareholder Information - The number of shareholders reached 23,514 by the end of the reporting period[9] - The largest shareholder, China National Chemical Corporation, holds 57.37% of the shares[9] Research and Development - Research and development expenses increased by 58.14% to ¥69,397,904.17 from ¥43,884,807.84, reflecting a higher investment in technology[12] - Research and development expenses for Q1 2021 were CNY 69,397,904.17, up 58.5% from CNY 43,884,807.84 in Q1 2020[28] Operational Costs - Operating costs rose significantly, with a cost of sales of ¥1,333,079,085.67, up 48.08% from ¥900,221,202.24, driven by raw material price fluctuations[12] - Total operating costs for Q1 2021 were ¥1,509,309,538.37, up from ¥1,040,755,442.06 in Q1 2020, indicating an increase of about 45%[24] Future Outlook - The company is focusing on expanding its market presence and enhancing its product offerings through new technology development[1] - Future guidance indicates a strategic emphasis on improving operational efficiency and exploring potential mergers and acquisitions[1]